Works matching IS 1470269X AND DT 2012 AND VI 12 AND IP 4

Results: 11

Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 277, doi. 10.1038/tpj.2012.28

By:

Savonarola, A;
Palmirotta, R;
Guadagni, F;
Silvestris, F

Publication type:

Article

Optimization of warfarin dose by population-specific pharmacogenomic algorithm.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 306, doi. 10.1038/tpj.2011.4

By:

Pavani, A;
Naushad, S M;
Rupasree, Y;
Kumar, T R;
Malempati, A R;
Pinjala, R K;
Mishra, R C;
Kutala, V K

Publication type:

Article

Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 349, doi. 10.1038/tpj.2011.19

By:

Swan, G E;
Javitz, H S;
Jack, L M;
Wessel, J;
Michel, M;
Hinds, D A;
Stokowksi, R P;
McClure, J B;
Catz, S L;
Richards, J;
Zbikowski, S M;
Deprey, M;
McAfee, T;
Conti, D V;
Bergen, A W

Publication type:

Article

Pathway based analysis of genotypes in relation to alcohol dependence.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 342, doi. 10.1038/tpj.2011.10

By:

Reimers, M A;
Riley, B P;
Kalsi, G;
Kertes, D A;
Kendler, K S

Publication type:

Article

Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 297, doi. 10.1038/tpj.2011.5

By:

Scott, S A;
Martis, S;
Peter, I;
Kasai, Y;
Kornreich, R;
Desnick, R J

Publication type:

Article

Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 360, doi. 10.1038/tpj.2011.12

By:

Hecker, M;
Goertsches, R H;
Fatum, C;
Koczan, D;
Thiesen, H-J;
Guthke, R;
Zettl, U K

Publication type:

Article

Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 328, doi. 10.1038/tpj.2011.9

By:

Gupta, A;
Schulze, T G;
Nagarajan, V;
Akula, N;
Corona, W;
Jiang, X-y;
Hunter, N;
McMahon, F J;
Detera-Wadleigh, S D

Publication type:

Article

Economic impact of a genetic test for cisplatin-induced ototoxicity.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 359, doi. 10.1038/tpj.2011.21

By:

Dionne, F;
Mitton, C;
Rassekh, R;
Brooks, B;
Ross, C;
Hayden, M;
Carleton, B

Publication type:

Article

Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 319, doi. 10.1038/tpj.2011.6

By:

Levran, O;
Peles, E;
Hamon, S;
Randesi, M;
Zhao, C;
Zhang, B;
Adelson, M;
Kreek, M J

Publication type:

Article

Translational aspects of genetic factors in the prediction of drug response variability: a case study of warfarin pharmacogenomics in a multi-ethnic cohort from Asia.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 312, doi. 10.1038/tpj.2011.7

By:

Chan, S L;
Suo, C;
Lee, S C;
Goh, B C;
Chia, K S;
Teo, Y Y

Publication type:

Article

SNP discovery, expression and cis-regulatory variation in the UGT2B genes.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 4, p. 287, doi. 10.1038/tpj.2011.2

By:

Sun, C;
Southard, C;
Huo, D;
Hernandez, R D;
Witonsky, D B;
Olopade, O I;
Di Rienzo, A

Publication type:

Article